Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8HXR

Nanobody2 in complex with human BCMA ECD

Summary for 8HXR
Entry DOI10.2210/pdb8hxr/pdb
DescriptorNanobody2, Tumor necrosis factor receptor superfamily member 17 (3 entities in total)
Functional Keywordscomplex, nanobody, immune system
Biological sourceVicugna pacos
More
Total number of polymer chains4
Total formula weight39072.06
Authors
Sun, Y.,Zhang, B. (deposition date: 2023-01-05, release date: 2024-01-03, Last modification date: 2024-11-13)
Primary citationSun, Y.,Yang, X.N.,Yang, S.S.,Lyu, Y.Z.,Zhang, B.,Liu, K.W.,Li, N.,Cui, J.C.,Huang, G.X.,Liu, C.L.,Xu, J.,Mi, J.Q.,Chen, Z.,Fan, X.H.,Chen, S.J.,Chen, S.
Antigen-induced chimeric antigen receptor multimerization amplifies on-tumor cytotoxicity.
Signal Transduct Target Ther, 8:445-445, 2023
Cited by
PubMed Abstract: Ligand-induced receptor dimerization or oligomerization is a widespread mechanism for ensuring communication specificity, safeguarding receptor activation, and facilitating amplification of signal transduction across the cellular membrane. However, cell-surface antigen-induced multimerization (dubbed AIM herein) has not yet been consciously leveraged in chimeric antigen receptor (CAR) engineering for enriching T cell-based therapies. We co-developed ciltacabtagene autoleucel (cilta-cel), whose CAR incorporates two B-cell maturation antigen (BCMA)-targeted nanobodies in tandem, for treating multiple myeloma. Here we elucidated a structural and functional model in which BCMA-induced cilta-cel CAR multimerization amplifies myeloma-targeted T cell-mediated cytotoxicity. Crystallographic analysis of BCMA-nanobody complexes revealed atomic details of antigen-antibody hetero-multimerization whilst analytical ultracentrifugation and small-angle X-ray scattering characterized interdependent BCMA apposition and CAR juxtaposition in solution. BCMA-induced nanobody CAR multimerization enhanced cytotoxicity, alongside elevated immune synapse formation and cytotoxicity-mediating cytokine release, towards myeloma-derived cells. Our results provide a framework for contemplating the AIM approach in designing next-generation CARs.
PubMed: 38062078
DOI: 10.1038/s41392-023-01686-z
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.7 Å)
Structure validation

237735

數據於2025-06-18公開中

PDB statisticsPDBj update infoContact PDBjnumon